Psych Vivas · Child and adolescent psychiatry — OCRD
Childhood-onset OCD — structured clinical viva
Fellowship viva covering paediatric OCD stepped care, family accommodation, SSRI adequacy, POTS evidence, and PANDAS/psychosis traps.
On this page & tools
Target exams
Interpretation
Reveal interpretation
This is severe paediatric OCD with inadequate prior psychological treatment (no true ERP), likely under-dosed/under-duration SSRI, high family accommodation, school crisis, and parental pressure for antipsychotic plus PANDAS medicalisation — not a first-line antipsychotic case.[3][5]
Formulation. Multi-dimensional OCD with negative reinforcement of rituals and accommodation; school impairment and peer stress; risk of shame and secondary mood symptoms. Measure with CY-BOCS serially.[4]
Psychological care. Name ERP: hierarchy, response prevention for washing/checking/mental rituals, reduce reassurance. Coach parents to withdraw accommodation gradually with support. Supportive counselling is not an adequate ERP trial.[3][5]
Medication. Three weeks at 50 mg is not an adequate OCD SSRI trial. Optimise sertraline toward therapeutic paediatric OCD ranges with black-box monitoring (activation/suicidality), or switch within SSRI class if intolerability after true adequacy — March sertraline evidence; POTS supports sertraline and combination with CBT for severity.[1][7][3]
POTS II lesson. If partial response after optimised SRI, add CBT rather than medication-only management.[2]
Antipsychotic request. Not first-line for primary OCD thoughts. Adult refractory antipsychotic augmentation evidence exists but is specialist, low-dose, monitored, after SRI and ERP adequacy — not for three-week under-treatment.[8][3]
PANDAS. Acknowledge concept (Swedo). Gradual multi-year OCD with remote sore throat is not classic abrupt PANDAS; do not delay ERP/SSRI for speculative antibiotics. Specialist input only if acute-onset criteria truly met.[6][3]
School. Liaison letter: staged bathroom plan, anti-bullying, exam accommodations, collaborative attendance plan without endless ritual enabling.[3]
Key points
[1] [2] [3] [8]References
- [1]Pediatric OCD Treatment Study (POTS) Team Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder: the Pediatric OCD Treatment Study (POTS) randomized controlled trial JAMA, 2004.PMID 15507582
- [2]Franklin ME, Sapyta J, Freeman JB, et al. Cognitive behavior therapy augmentation of pharmacotherapy in pediatric obsessive-compulsive disorder: the Pediatric OCD Treatment Study II (POTS II) randomized controlled trial JAMA, 2011.PMID 21934055
- [3]American Academy of Child and Adolescent Psychiatry Practice parameter for the assessment and treatment of children and adolescents with obsessive-compulsive disorder J Am Acad Child Adolesc Psychiatry, 2012.PMID 22176943
- [4]Scahill L, Riddle MA, McSwiggin-Hardin M, et al. Children's Yale-Brown Obsessive Compulsive Scale: reliability and validity J Am Acad Child Adolesc Psychiatry, 1997.PMID 9183141
- [5]Calvocoressi L, Lewis B, Harris M, et al. Family accommodation in obsessive-compulsive disorder Am J Psychiatry, 1995.PMID 7864273
- [6]Swedo SE, Leonard HL, Garvey M, et al. Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases Am J Psychiatry, 1998.PMID 9464208
- [7]March JS, Biederman J, Wolkow R, et al. Sertraline in children and adolescents with obsessive-compulsive disorder: a multicenter randomized controlled trial JAMA, 1998.PMID 9842950
- [8]Bloch MH, Landeros-Weisenberger A, Kelmendi B, et al. A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder Mol Psychiatry, 2006.PMID 16585942